These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3023666)

  • 1. p37mos-associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos.
    Singh B; Hannink M; Donoghue DJ; Arlinghaus RB
    J Virol; 1986 Dec; 60(3):1148-52. PubMed ID: 3023666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histidine-221 to tyrosine substitution in v-mos abolishes its biological function and its protein kinase activity.
    Singh B; Wittenberg C; Hannink M; Reed SI; Donoghue DJ; Arlinghaus RB
    Virology; 1988 May; 164(1):114-20. PubMed ID: 2966489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of site-specific antipeptide antibodies to perturb the serine kinase catalytic activity of p37mos.
    Maxwell SA; Arlinghaus RB
    J Virol; 1985 Sep; 55(3):874-6. PubMed ID: 2991608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine kinase activity associated with Maloney murine sarcoma virus-124-encoded p37mos.
    Maxwell SA; Arlinghaus RB
    Virology; 1985 May; 143(1):321-33. PubMed ID: 2998008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysine residue 121 in the proposed ATP-binding site of the v-mos protein is required for transformation.
    Hannink M; Donoghue DJ
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):7894-8. PubMed ID: 2999782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming mutant v-mos protein kinases that are deficient in in vitro autophosphorylation.
    Freeman RS; Donoghue DJ
    Mol Cell Biol; 1989 Sep; 9(9):4087-90. PubMed ID: 2528689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologically active mutants with deletions in the v-mos oncogene assayed with retroviral vectors.
    Bold RJ; Donoghue DJ
    Mol Cell Biol; 1985 Nov; 5(11):3131-8. PubMed ID: 3018503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vimentin phosphorylation by p37mos protein kinase in vitro and generation of a 50-kDa cleavage product in v-mos-transformed cells.
    Singh B; Arlinghaus RB
    Virology; 1989 Nov; 173(1):144-56. PubMed ID: 2554568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the mouse mammary tumor virus long terminal repeat to promote steroid-inducible expression of v-mos.
    Papkoff J; Ringold GM
    J Virol; 1984 Nov; 52(2):420-30. PubMed ID: 6092668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functions of the mos oncogene family and associated gene products.
    Bold RJ; Hannink M; Donoghue DJ
    Cancer Surv; 1986; 5(2):243-55. PubMed ID: 2946405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cAMP-independent serine/threonine kinase activity is associated with the mos sequences of ts110 Moloney murine sarcoma virus-encoded P85gag-mos.
    Maxwell SA; Arlinghaus RB
    J Gen Virol; 1985 Oct; 66 ( Pt 10)():2135-46. PubMed ID: 2995551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of v-mos encoded proteins in cells transformed by several related murine sarcoma viruses.
    Papkoff J; Lai MH; Hunter T
    J Cell Biochem; 1982; 19(4):349-62. PubMed ID: 6298255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transforming protein of Moloney murine sarcoma virus is a soluble cytoplasmic protein.
    Papkoff J; Nigg EA; Hunter T
    Cell; 1983 May; 33(1):161-72. PubMed ID: 6380747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of mutant and wild-type MC29 v-myc alleles and biochemical properties of their protein products.
    Bister K; Trachmann C; Jansen HW; Schroeer B; Patschinsky T
    Oncogene; 1987 May; 1(2):97-109. PubMed ID: 3438084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An invariant asparagine residue belonging to a highly conserved domain in all protein kinases is instrumental in the protein kinase activity of the v-mil gene product.
    Denhez F; Galibert F; Heimann B; Dozier C; Graf T; Moelling K; Stehelin D; Ghysdael J
    Oncogene Res; 1988 Sep; 3(2):199-205. PubMed ID: 2852340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moloney murine sarcoma virus encoded p37mos expressed in yeast has protein kinase activity.
    Singh B; Wittenberg C; Reed SI; Arlinghaus RB
    Virology; 1986 Jul; 152(2):502-6. PubMed ID: 3014729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. v-mos protein produced by in vitro translation has protein kinase activity.
    Herzog NK; Nash M; Ramagli LS; Arlinghaus RB
    J Virol; 1990 Jun; 64(6):3093-6. PubMed ID: 2159564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
    Topol LZ; Marx M; Calothy G; Blair DG
    Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine- and threonine-specific protein kinase activities of purified gag-mil and gag-raf proteins.
    Moelling K; Heimann B; Beimling P; Rapp UR; Sander T
    Nature; 1984 Dec 6-12; 312(5994):558-61. PubMed ID: 6438534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of protein tyrosine phosphatase 1B and casein as substrates for 124-v-Mos.
    Proikas-Cezanne T; Stabel S; Riethmacher D
    BMC Biochem; 2002 Apr; 3():6. PubMed ID: 12022922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.